tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

QALY

0

CVS Caremark’s foray into cost-effectiveness analysis raises questions about the future of prescription medicines in America

Posted on September 25, 2018 by Patti Peeples, R.Ph., Ph.D.

Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, CVS Caremark announced in August that it would allow self-funded insurers to exclude from their plan any drug launched at… Continue Reading →

cost-effectiveness, cost-effectiveness analysis, CVS Caremark, HealthEconomics.Com, HEOR, ICER, PBM, pharmaceutical, Pharmaceutical Pricing, Pharmacy Benefit Manager Catherine Stevenson, cost-effectiveness analysis, CVS Caremark, drug pricing, HealthEconomics.Com, ICER, patti peeples, PBM, QALY, value-based pricing

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • Will 2023 Be the Year AI Disrupts Healthcare?
  • Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World
  • Podcast Q&A: Achieving Consensus When Everyone is an Expert, but No One Agrees
  • Podcast Q&A: Social Media Data: Opportunities and Insights for Clinical Research

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
4h

How are #payers reacting to the Inflation Reduction Act? Help us find out! - https://mailchi.mp/healtheconomics.com/how-are-payers-reacting-to-the-inflation-reduction-act-help-us-find-out #marketaccess #pharma

Reply on Twitter 1620769094160064513 Retweet on Twitter 1620769094160064513 Like on Twitter 1620769094160064513 Twitter 1620769094160064513
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
17h

Boehringer Ingelheim Reveals Positive Trial Results for Rare Psoriasis Therapeutic

http://ow.ly/6yf050MG6if

#HEOR #RareDisease #Therapeutics #ClinicalTrials #Research

Reply on Twitter 1620567651561906180 Retweet on Twitter 1620567651561906180 Like on Twitter 1620567651561906180 Twitter 1620567651561906180
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
18h

Moderna and Pfizer COVID-19 Vaccine 4X Price Increase Worries UK and US Lawmakers

http://ow.ly/hlAo50MG413

#HEOR #Vaccines #COVID19 #DrugPrices #DrugPricing

Reply on Twitter 1620552552113750016 Retweet on Twitter 1620552552113750016 Like on Twitter 1620552552113750016 Twitter 1620552552113750016
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2023 tHEORetically Speaking. All rights reserved.
Hiero by aThemes